Canadian HIV & Viral Hepatitis Pharmacists Network (CHAP) Resources
References and Resources for Trainees
Antiretroviral Reimbursement
- Reimbursement status of antiretrovirals in Canada
- Reimbursement status of PrEP in Canada
- Public prescription drug plan coverage for antiretrovirals and the potential cost to people living with HIV in Canada: a descriptive study. Yoong D et al. CMAJ Open 2018;6:E551-560.
- CHAP position statement on Universal Access to Antiretroviral Drugs in Canada (2017)
Tools/Resources
- Antiretroviral Reference Tool for Pharmacists
- A Management Tool for HIV Drug-Drug Interactions – English
- A Management Tool for HIV Drug-Drug Interactions – French
- Medication Reconciliation Form (MedsCheck) – 2015 Version, English
- Quebec Antiretroviral Therapeutic Drug Monitoring Program – English
- Quebec Antiretroviral Therapeutic Drug Monitoring Program – French
- A Tool for Preventing and Managing Bone Disease in HIV-infected Adults
- A Guide to Assessing Antiretroviral Therapy in HIV Hospitalized Patients
- A Guide to Assessing Antiretroviral Therapy in HIV Hospitalized Patients – Pocket Card
CHAP101 Learning Series
- Tackling ART Resistance: Part 1 (Linda Robinson) Passcode: oYwb?0kD
- Tackling ART Resistance: Part 2 (Linda Robinson) Passcode: 2Njp&e3^
- Tackling ART Resistance: Part 3 (Linda Robinson) Passcode: LE@v7s&f
The CHAP101 Learning Series is supported via an educational grant from Merck Canada. The presentations were independently developed and reflect the opinions of the presenter (L. Robinson).
Goals:
To promote cross-country sharing of experiences and information to improve patient care.
To develop practical, clinical guidelines on the role of the pharmacist in caring for patients with HIV and/or viral hepatitis.
To collaborate on research protocols which demonstrate positive drug-related outcomes.
To share continuing education resources, in order to make information on HIV and/or viral hepatitis drug therapy more accessible to community, hospital and ambulatory pharmacists, as well as patients.
To foster the development of HIV and/or viral hepatitis pharmacist mentors.
To promote the pharmacists role in HIV and/or viral hepatitis therapeutics on a national level.